Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Increased Mitochondrial Mass Leads to Heightened Pyroptosis that Drives CD4+ T Cell Depletion in Patients with HIV-1 Infection
28 Pages Posted: 13 Nov 2019
More...Abstract
In HIV-1 infection, over 90% CD4+ T cells have died of caspase-1 mediated pyroptosis. What governs the increased susceptibility of CD4+ T cells to pyroptosis is poorly understood. Here, we examined the involvement of mitochondria in pyroptosis. Mitochondrial mass (MM) levels are significantly higher in CD4+ T cells from HIV-infected patients than that in healthy controls, and cells with the MMhigh phenotype manifest greater sensitivity to caspase-1 mediated pyroptosis. Moreover, the increased MM is more pronounced in the early differentiated and inactivated CD4+ T cells. However, higher MM is not intrinsically linked to T cell differentiation disorder or excessive activation of CD4+ T cells. Mechanistically, the increased MM is significantly correlated with an elevated expression of the mitochondrial fusion gene Mfn1. Additionally, MM increase in CD4+ T cells is associated with heightened sensitivity of these cells to pyroptosis in HIV-1 infected patients whom were either treated with antiretroviral drugs or not. These results reveal a previously unknown mechanism that links mitochondrial change to pyroptosis, and suggest that modulation of this interaction may help to prevent CD4+ T cell loss in HIV infection.
Funding Statement: This work was funded in part by The National 13th Five-Year Plan’s Grand Program on Key Infectious Disease Control (2018ZX10302-102 to F.Z., 2018ZX10715-005 to H.Z.), the National Natural Science Foundation of China (NSFC81672000 to H.Z.), the Culture Project of Beijing Municipal Commission of Health and Family Planning (215-3-109 to L.W.), the Science and technology innovation service capacity building (1192070325 to F.Z.).
Declaration of Interests: The authors have no conflicts of interest to declare.
Ethics Approval Statement: Written informed consent was obtained from each subject. The local human research subject review board (RSRB) approved the study.
Keywords: HIV/AIDS; CD4+ T cell; Pyroptosis; Mitochondrial mass; Mfn1
Suggested Citation: Suggested Citation